Pharsight
Ask Pharsight
AOP ORPHAN PHARMACEUTICALS AG PATENTS FACING OPPOSITIONS
Top patents of AOP ORPHAN PHARMACEUTICALS AG facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP2988750B1
19 Jan, 2022
Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias
Apr, 2034
1